040760 UK Health- and Pharmaceutical Economics (BA) (2021S)
Track in Competition and Regulation
Continuous assessment of course work
Labels
MIXED
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Th 11.02.2021 09:00 to Mo 22.02.2021 12:00
- Deregistration possible until We 31.03.2021 23:59
Details
max. 30 participants
Language: German
Lecturers
Classes (iCal) - next class is marked with N
Hybride Lehrveranstaltung
Friday
26.03.
13:15 - 18:15
Digital
Saturday
27.03.
09:45 - 13:00
Digital
Friday
07.05.
13:15 - 18:15
Hybride Lehre
Hörsaal 13 Oskar-Morgenstern-Platz 1 2.Stock
Hörsaal 13 Oskar-Morgenstern-Platz 1 2.Stock
Saturday
08.05.
09:45 - 13:00
Hybride Lehre
Hörsaal 6 Oskar-Morgenstern-Platz 1 1.Stock
Hörsaal 6 Oskar-Morgenstern-Platz 1 1.Stock
Friday
04.06.
13:15 - 18:15
Hybride Lehre
Hörsaal 13 Oskar-Morgenstern-Platz 1 2.Stock
Hörsaal 13 Oskar-Morgenstern-Platz 1 2.Stock
Saturday
05.06.
09:45 - 11:15
Hybride Lehre
Hörsaal 4 Oskar-Morgenstern-Platz 1 Erdgeschoß
Hörsaal 4 Oskar-Morgenstern-Platz 1 Erdgeschoß
Information
Aims, contents and method of the course
Assessment and permitted materials
Assigned Presentation (15 -20 Min)
Written final Exam
Written final Exam
Minimum requirements and assessment criteria
Presentation and exam both contribute 50% to final grade.
To achieve a positive grade in the test, at least 50% of the points in the written test are necessary
To achieve a positive grade in the test, at least 50% of the points in the written test are necessary
Examination topics
Reading list
Association in the course directory
Last modified: Fr 12.05.2023 00:13
• Forms of Delivery of Medical Care
• Paying Providers
• Physicians as Suppliers of Medical Services
• Austrian Health Care System
Literature:
Breyer, F./Zweifel, P. Kifmann, M (2013), Gesundheitsökonomik, Springer. (Chapters 8, 10, 12)Part 2: Health Economic Evaluation
• Health Technology Assessment (HTA) across countries
• Cost Effectiveness analysis
• Cost utility analysis
• Cost benefit analysis
• Comparative effectiveness
• Decision analytic modeling (e.g. Markov Models)
• Evidenced based Medicine
Literature:
Drummond, M/Sculpher, M./Torrance, G./O’Brien, B./Stoddart, G. (2015), Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press (Chapters 5, 6, 7, 9)
Additional reading:
Schöffski, O. Graf v.d. Schulenburg, M. (Hg.) (2008), Gesundheitsökonomische Evaluationen, Springer.Part 3 Pharmaceutical Economics
• The pharmaceutical Industry
• Pharmaceutical R&D process
• Costs and returns on pharmaceutical R&D
• Pricing Pharmaceuticals
• Pharmaceutical Regulation (e.g. patent legislation)
• Drug MarketingLiterature:
Schweitzer, S. (2007), Pharmaceutical Economics and Policy, Oxford University Press. (Chapters 1, 4, 6, 8, 12)